# ANDEMBRY
> **BLA761367** · Biologics License Application · Sponsor: CSL BEHRING LLC · Approved 2025-06-16
## Drug
- **FDA Application Number:** BLA761367
- **Application type:** Biologics License Application
- **Brand name:** ANDEMBRY
- **Generic name:** GARADACIMAB
- **Active ingredients:** GARADACIMAB-GXII
- **Dosage form:** INJECTABLE
- **Route:** SUBCUTANEOUS
- **Marketing status:** Prescription
- **Sponsor:** CSL BEHRING LLC
- **Manufacturer:** CSL
- **First approval:** 2025-06-16
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761367)
---
*AI Analytics · CC0 1.0*